SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-176599
Filing Date
2022-06-17
Accepted
2022-06-17 16:52:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d314935dsc13da.htm SC 13D/A 40487
  Complete submission text file 0001193125-22-176599.txt   41917
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Subject) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90404 | Film No.: 221024666
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 GLOUCESTER PLACE LONDON XX W1U6HP
Business Address
Sinclair Michael (Filed by) CIK: 0001551246 (see all company filings)

Type: SC 13D/A